BiotechTube
Home/Pipeline/Asthma Candidate

Asthma Candidate

Asthma

Phase 3ActiveN/A

Key Facts

Indication
Asthma
Phase
Phase 3
Status
Active
Company
Teva

About Teva

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical leader with a dual strategy of being a generics/biosimilars powerhouse and an innovative specialty medicines developer. Its mission, 'We are all in for better health,' is executed through a focus on neuroscience and immunology, leveraging strategic partnerships and a robust pipeline. The company is currently in the 'Acceleration Phase' of its 'Pivot to Growth' plan, aiming for consistent financial performance and pipeline execution, having delivered three consecutive years of growth as of 2025.

View full company profile

Therapeutic Areas

NeuroscienceImmunology

Other Asthma Drugs

DrugCompanyPhase
Chitinase InhibitorLead Discovery SienaDiscovery
RIG-101RIGImmunePre-clinical
SKB378Klus PharmaPhase 1
Asthma Clinical TrialsAmerican Health ResearchNot Disclosed
Advanced Asthma ProductsPolpharmaNot Disclosed
SolrikitugUniquity BioPhase 2
Asthma TrialScience 37Phase 3
CAL-4Calyxha BiotechnologiesPreclinical
FlutiformKYORIN PharmaceuticalMarketed
Novel Immunology CandidateTeva Pharmaceutical IndustriesPhase 3
Zumilokibart (APG777)Apogee TherapeuticsPhase 1
APG808Apogee TherapeuticsPhase 1b